Merck KGaA
XHAN:MRK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck KGaA
XHAN:MRK
|
DE |
|
P
|
PriceSmart Inc
F:PS8
|
US |
|
U
|
Unilever PLC
VSE:ULVR
|
UK |
|
V
|
Vista Gold Corp
TSX:VGZ
|
US |
|
M
|
Melia Hotels International SA
XMUN:MEL
|
ES |
Intrinsic Value
Is MRK undervalued or overvalued?
See the intrinsic value estimate for 
Merck KGaA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Merck KGaA Does
Merck KGaA is a German science and technology company that makes medicines, lab tools, and specialty materials. Its healthcare business sells prescription drugs and treatments, especially in cancer, fertility, and neurology. Its life science business sells chemicals, testing products, and equipment that researchers and drugmakers use in labs and factories.
- Headquarters
- Germany DE
- Employees
- 62 461
- IPO date
- Oct 20, 1995
Merck KGaA has no economic moat
Competing medicines and alternative suppliers leave Merck KGaA without dependable protection across its businesses. Its patents and established customer relationships protect some products, but do not provide a lasting barrier around the whole company.
Read the full moat analysis
Revenue & Expenses Breakdown
Merck KGaA
Earnings Waterfall
Merck KGaA
The intrinsic value for Merck KGaA (MRK) under the Base Case is hidden EUR.
Compared with the current market price of 149.2 EUR, the stock appears hidden.